These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20672660)

  • 41. Point-of-care testing for CXCL13 in Lyme neuroborreliosis.
    Pietikäinen A; Oksi J; Hytönen J
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):226-228. PubMed ID: 29567125
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful treatment of neuroborreliosis in an HIV patient with simultaneous Borrelia, HIV-1 and Epstein-Barr virus genomes in liquor.
    de Pont CD; Lowe SH; Goossens VJ
    AIDS; 2013 Apr; 27(7):1196-7. PubMed ID: 23902926
    [No Abstract]   [Full Text] [Related]  

  • 43. Acute isolated partial oculomotor nerve palsy due to Lyme neuroborreliosis in a 5 year old girl.
    Drenckhahn A; Spors B; Knierim E
    Eur J Paediatr Neurol; 2016 Nov; 20(6):977-979. PubMed ID: 27323659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Penicillin V treatment in erythema migrans can give a false security].
    Wahlberg P; Nyman D
    Lakartidningen; 2006 Mar 1-7; 103(9):668. PubMed ID: 16583549
    [No Abstract]   [Full Text] [Related]  

  • 45. Neuroborreliosis and acute encephalopathy: The use of CXCL13 as a biomarker in CNS manifestations of Lyme borreliosis.
    Karrasch M; Fingerle V; Boden K; Darr A; Baier M; Straube E; Nenadic I
    Ticks Tick Borne Dis; 2018 Feb; 9(2):415-417. PubMed ID: 29246814
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lyme chondritis presenting as painless ear erythema.
    Srinivasalu H; Brescia AC; Rose CD
    Pediatrics; 2013 Jun; 131(6):e1977-81. PubMed ID: 23669522
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral Doxycycline Compared to Intravenous Ceftriaxone in the Treatment of Lyme Neuroborreliosis: A Multicenter, Equivalence, Randomized, Open-label Trial.
    Kortela E; Kanerva MJ; Puustinen J; Hurme S; Airas L; Lauhio A; Hohenthal U; Jalava-Karvinen P; Nieminen T; Finnilä T; Häggblom T; Pietikäinen A; Koivisto M; Vilhonen J; Marttila-Vaara M; Hytönen J; Oksi J
    Clin Infect Dis; 2021 Apr; 72(8):1323-1331. PubMed ID: 32133487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid.
    van Burgel ND; Bakels F; Kroes AC; van Dam AP
    J Clin Microbiol; 2011 May; 49(5):2027-30. PubMed ID: 21367992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis.
    Rupprecht TA; Pfister HW; Angele B; Kastenbauer S; Wilske B; Koedel U
    Neurology; 2005 Aug; 65(3):448-50. PubMed ID: 16087912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic neuroborreliosis in infancy.
    Zamponi N; Cardinali C; Tavoni MA; Porfiri L; Rossi R; Manca A
    Ital J Neurol Sci; 1999 Oct; 20(5):303-7. PubMed ID: 10933439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Acquired nystagmus in a 12-year-old boy as initial presentation of Lyme disease].
    Samimi S; Salah S; Bonicel P
    J Fr Ophtalmol; 2011 May; 34(5):325.e1-3. PubMed ID: 21496946
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Reddish-blue color lower leg with distinct vessel design. "Venous insufficiency" was Lyme borreliosis].
    Jäckle R
    MMW Fortschr Med; 2003 Jun; 145(24):18. PubMed ID: 12866293
    [No Abstract]   [Full Text] [Related]  

  • 53. Procalcitonin levels in patients with Lyme borreliosis.
    Lotric-Furlan S; Maraspin-Carman V; Cimperman J; Ogrinc K; Stopar T; Strle F
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):530-2. PubMed ID: 12422595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Acute abdominal pain caused by neuroborreliosis].
    Dobbe ASM; Zoethout AC; Bleeker WA; Oenema DG
    Ned Tijdschr Geneeskd; 2018 Jul; 162():. PubMed ID: 30040309
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lyme neuroborreliosis presenting as Alice in Wonderland syndrome.
    Binalsheikh IM; Griesemer D; Wang S; Alvarez-Altalef R
    Pediatr Neurol; 2012 Mar; 46(3):185-6. PubMed ID: 22353296
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ongoing discussion about the US clinical Lyme trials.
    Fallon BA; Petkova E; Keilp JG; Britton CB
    Am J Med; 2014 Feb; 127(2):e7. PubMed ID: 24462018
    [No Abstract]   [Full Text] [Related]  

  • 57. Chemokine Ligand 13 (CXCL13) in Neuroborreliosis and Neurosyphilis as Selected Spirochetal Neurological Diseases: A Review of Its Diagnostic Significance.
    Gudowska-Sawczuk M; Mroczko B
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331231
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lyme disease: European perspective.
    Stanek G; Strle F
    Infect Dis Clin North Am; 2008 Jun; 22(2):327-39, vii. PubMed ID: 18452805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anterocollis and startle myoclonus due to Lyme meningomyeloradiculitis.
    Schneider A; Pischinger B; Wimmer S; Topakian R
    Acta Neurol Belg; 2017 Mar; 117(1):317-318. PubMed ID: 27037820
    [No Abstract]   [Full Text] [Related]  

  • 60. Oral concerns in Lyme disease.
    Rhodus NL; Falace DA
    Northwest Dent; 2002; 81(2):17-8. PubMed ID: 11989326
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.